Company Filing History:
1 out of 2,405 
1 out of 47 
Years Active: 2013
Title: Shuliang Lee: Innovator in Cancer Treatment
Introduction
Shuliang Lee is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on inhibitors of Akt activity, which play a crucial role in cancer therapy.
Latest Patents
Shuliang Lee holds 1 patent for his invention titled "Inhibitors of Akt activity." This patent provides for substituted fused naphthyridine derivatives that inhibit Akt activity. The compounds disclosed in this patent selectively inhibit one or two of the Akt isoforms. Additionally, the invention includes compositions comprising such inhibitory compounds and methods for administering the compound to patients in need of cancer treatment.
Career Highlights
Throughout his career, Shuliang Lee has worked with prominent companies in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and MSD K.K. His experience in these organizations has allowed him to develop and refine his expertise in drug development and innovation.
Collaborations
Shuliang Lee has collaborated with esteemed colleagues such as Weiming Fan and Thomas F N Haxell. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Shuliang Lee's contributions to cancer treatment through his innovative patents and collaborations highlight his importance in the field of pharmaceutical research. His work continues to pave the way for new therapeutic options for patients battling cancer.